It could therefore seem surprising that Reader 1 had a systematic, although statistically borderline non-significant, higher sensitivity than Reader 2, ( p = 0.0505) This is, however, in agreement with the results of studies comparing radiographer and radiologist reading.
PARG expression was borderline non-significant in multivariate analysis ( p = 0.051 and 0.056 respectively) (Supplementary Table S6 ).
While SFA showed a borderline non-significant trend toward being higher in patients with CRS grade 1 than those with grade 2 (80.95 [52.09] vs. 52.71 [42.36] cm 2 , respectively; P = 0.051).
Participants without diabetes showed a significant association (OR = 1.087, 95% CI: 1.034–1.143, P = 0.002), while those with diabetes showed a borderline non-significant result (OR = 1.062, 95% CI: 1.000–1.129, P = 0.051).
Area of residence had minimal impact, with the South compared to the Center showing a borderline non-significant trend toward lower attitude scores (estimate = −1.269, SE = 0.651, p = 0.051), while no differences between the North and the Center could be found (estimate = 0.398, SE = 0.451, p = 0.378).
bimodal contrast was borderline non-significant ( p = 0.051).
A cutoff of 20 mm also showed a borderline non-significant trend ( P = 0.051; OR = 0.405, 95% CI: 0.163–1.004).
The subscapular skinfold showed a borderline non-significant difference between the groups ( p = 0.051).
However, unlike the univariate models, the full model revealed a borderline non-significant effect of breathing type at both the food web and top predator levels ( p = 0.051 and p = 0.057, respectively).
The job replacement subscale showed a negative but borderline non-significant association (B = − 0.357; β=−0.124; p = 0.051), which may indicate a limited relationship between concerns about job displacement and attitudes.
Waist circumference was borderline non-significant after adjustment (adjusted p = 0.0513), while outcomes that were non-significant in the primary analyses — including body weight, BMI, MACK-3 score, triglycerides, LDL-C, total cholesterol, HbA1c, waist–hip ratio, and HDL-C — remained non-significant ( Table 10 ).
C2528 again demonstrated an increased risk although this was now weak and borderline non-significant (HR 1.52, 95% CI 0.99–2.31, p = 0.052).
(2023) study [ 17 ] yielded a modest shift in the pooled estimate that was borderline non-significant (g = 0.11, p = 0.052) and eliminated detectable heterogeneity (I2 = 0%).
Effect of Treatment on Glucose Metabolism Markers Fasting blood glucose (FBG): The baseline FBG levels appeared to be slightly higher for the active treatment group (7 mmol/L) than the placebo group (6 mmol/L) but this was borderline non-significant ( p = 0.052) ( Table 2 ).
The pairwise difference in median viral loads between Antwerp and East Flanders is borderline non-significant (p-value = 0.052).
An initial approach to differences in patient outcomes showed that regarding PS, a statistically significant difference of mild versus severe cases ( p = 0.041) was observed, while the difference between mild and moderate cases was borderline non-significant ( p = 0.052).
To test if this preference for high calorie food differed between groups, a linear mixed effects model revealed a small, borderline non-significant main effect of calorie level (high vs. low) on stimulus value ratings ( β calorie level = 0.02 ± 0.01, t(506) = 1.95, p = 0.052, 95% CI [2.20e-4 to 0.05]) and a significant main effect of group ( β group = 0.09 ± 0.03, t(506) = 2.71, p < 0.001, 95% CI [0.02–0.15]).
In summary, although borderline non-significant (p = 0.052), we observed pronounced intra-group (WB-EMS vs CG) differences in men, while the effect of WB-EMS on VAT changes was negligible in women (p = 0.911). 3.2 Confounding factors After the intervention period, no significant changes within the groups or between-group differences in physical activity (p = 0.124), exercise participation ≥60 min/w (p = 0.607), or exercise volume (p = 0.976) were reported by the participants.
In unadjusted analyses, patients in the resolved SI change group had a lower likelihood of any post-acute SAED visit (OR = 0.10, 95% CI: 0.01–0.70, p = 0.04) and fewer total visits, though the latter was borderline non-significant (IRR = 0.11, 95% CI: 0.00–0.69, p = 0.052).
The double application group showed significant improvements from baseline at 30 days across all WOMAC outcomes and NPRS, as seen by the mean differences from baseline at the patient-level endpoint (last available visit): WOMAC Total −13.72 points (95% CI −18.25 to −9.19, r = 0.775, n = 57); Pain −2.53 (95% CI −3.60 to −1.46, r = 0.718); Stiffness −0.96 (95% CI −1.47 to −0.45, d = −0.50, paired t -test); Physical Function −10.23 (95% CI −13.47 to −6.99, r = 0.811); and NPRS −1.13 (95% CI −2.19 to −0.07, n = 38, Wilcoxon p = 0.052, borderline non-significant).
Respiratory conditions showed a borderline non-significant association ( p = 0.052), with higher prevalence in males (5.1% vs. 3.8%). 3.5.
Regarding PS, a statistically significant difference of mild versus severe cases was observed (p=0.041), while the difference between mild and moderate cases was borderline non-significant (p=0.052).
Although the full cycle analysis also indicated a main effect of synchrony, F (1, 18) = 9.29, P = 0.007, BF 10 = 7.08, η p 2 = 0.34, and a borderline non-significant effect of configuration, F (1, 18) = 4.31, P = 0.052, BF 10 = 1.36, η p 2 = 0.19, both effects went in the opposite direction as the half cycle results.
However, this association was attenuated and became borderline non-significant after full adjustment in Model 3 (OR=1.139, 95% CI: 0.988–1.314, p=0.053).
A borderline non-significant time effect was observed for peripheral systolic BP ( p = 0.053) and diastolic BP was reduced over time ( p = 0.027) with a non-significant time by treatment effect ( p = 0.053).